Efficacy The mortality ARRs were 8.3% (95% CI − 4.79 to 21.47) in France and 1.1% (95% CI − 5.87 to 8.16) in the ROW (Table 3 ); the difference in treatment effect did not reach statistical significance.
← all excerpts
Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET.
1
—
—